Sonoda K - Search Results

1

Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer.

Yahata H, Kodama K, Okugawa K, Hachisuga K, Yasutake N, Maenohara S, Yagi H, Yasunaga M, Ohgami T, Onoyama I, Asanoma K, Kobayashi H, Sonoda K, Baba S, Ishigami K, Ohishi Y, Oda Y, Kato K. Yahata H, et al. Among authors: sonoda k. Gynecol Oncol. 2022 Apr;165(1):149-154. doi: 10.1016/j.ygyno.2022.01.031. Epub 2022 Feb 10. Gynecol Oncol. 2022. PMID: 35151491

2

The promotion of invasion through the basement membrane of cervical carcinoma cells by fibronectin as a chemoattractant.

Sugihara K, Saito T, Okadome M, Sonoda K, Kobayashi H, Kamura T, Tsukamoto N, Nakano H. Sugihara K, et al. Among authors: sonoda k. Cancer Lett. 1994 May 16;79(2):167-73. doi: 10.1016/0304-3835(94)90256-9. Cancer Lett. 1994. PMID: 8019975

3

Angiogenesis in adenocarcinoma of the uterine cervix.

Kaku T, Hirakawa T, Kamura T, Amada S, Kinukawa N, Kobayashi H, Sakai K, Ariyoshi K, Sonoda K, Nakano H. Kaku T, et al. Among authors: sonoda k. Cancer. 1998 Oct 1;83(7):1384-90. doi: 10.1002/(sici)1097-0142(19981001)83:7<1384::aid-cncr16>3.0.co;2-0. Cancer. 1998. PMID: 9762940

4

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H. Kaku T, et al. Among authors: sonoda k. Clin Cancer Res. 1999 Jun;5(6):1449-53. Clin Cancer Res. 1999. PMID: 10389931

We previously established (K. Sonoda et al., Int. J. Oncol., 6: 1099-1104, 1995) a novel monoclonal antibody, 22-1-1, generated from adenocarcinoma of the uterine cervix, and 22-1-1 antigen (Ag) was expressed in cancer cells derived mainly from the uterus and ovary. …

We previously established (K. Sonoda et al., Int. J. Oncol., 6: 1099-1104, 1995) a novel monoclonal antibody, 22-1-1, generate …

5

The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.

Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Gynecol Oncol. 2000 Dec;79(3):424-9. doi: 10.1006/gyno.2000.5981. Gynecol Oncol. 2000. PMID: 11104614

6

Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.

Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E, Nakano H. Fujita T, et al. Among authors: sonoda k. Cancer Lett. 2003 Mar 31;192(2):161-9. doi: 10.1016/s0304-3835(02)00713-9. Cancer Lett. 2003. PMID: 12668280

7

Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.

Yahata H, Hirakawa T, Fujita T, Ariyoshi K, Sonoda K, Amada S, Kobayashi H, Nakano H. Yahata H, et al. Among authors: sonoda k. Int J Clin Oncol. 2004 Aug;9(4):317-21. doi: 10.1007/s10147-004-0400-x. Int J Clin Oncol. 2004. PMID: 15375709

8

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer.

Yagi H, Miyamoto S, Tanaka Y, Sonoda K, Kobayashi H, Kishikawa T, Iwamoto R, Mekada E, Nakano H. Yagi H, et al. Among authors: sonoda k. Br J Cancer. 2005 May 9;92(9):1737-45. doi: 10.1038/sj.bjc.6602536. Br J Cancer. 2005. PMID: 15827558 Free PMC article.

9

Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.

Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Gynecol Oncol. 2005 Jun;97(3):772-9. doi: 10.1016/j.ygyno.2005.02.025. Epub 2005 Apr 15. Gynecol Oncol. 2005. PMID: 15943986

10

Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.

Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H. Tanaka Y, et al. Among authors: sonoda k. Clin Cancer Res. 2005 Jul 1;11(13):4783-92. doi: 10.1158/1078-0432.CCR-04-1426. Clin Cancer Res. 2005. PMID: 16000575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

860 results

Search Page